Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging

This study has been completed.
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
Matthew MacCumber, Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00606138
First received: January 9, 2008
Last updated: May 25, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)